EXTENDED REPORT

¹ Division of Clinical Immunology and Rheumatology, Academic Medical Centre/University of Amsterdam, The Netherlands
² Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre/University of Amsterdam, The Netherlands
³ Department of Rheumatology, Ghent University Hospital, Belgium
⁴ Centre for Rheumatic Diseases, University of Glasgow, Scotland, UK
⁵ Rheumatology Department, St Vincent’s University Hospital, Dublin, Ireland

Correspondence to:
Professor P P Tak
Division of Clinical Immunology and Rheumatology, F4-218, Academic Medical Centre/University of Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, The Netherlands; p.p.tak{at}amc.uva.nl

Background: Previous work identified synovial sublining macrophage numbers as a potential biomarker for clinical efficacy in rheumatoid arthritis.

Objective: To investigate the association between changes in infiltration of synovial macrophages and clinical improvement after antirheumatic treatment.

Methods: 88 patients who participated in various clinical trials were studied. All patients underwent serial arthroscopy before initiation of treatment and after different time intervals. Immunohistochemical and digital image analysis were performed according to standardised procedures to detect changes in CD68+ synovial sublining macrophages in relationship to changes in the 28 joint count Disease Activity Score (DAS28). Statistical analysis was performed using one way analysis of variance, the independent samples t test, linear regression, and the standardised response mean (SRM).

Results: For good, moderate, and non-responders, according to the DAS28 response criteria, there was a significant difference in the change in sublining macrophages (mean (SEM) cells/mm² –643 (124), –270 (64), and –95 (60), respectively; p<0.0003). There was a significant correlation between the change in the number of macrophages and the change in DAS28 (Pearson correlation 0.874, p<0.01). The change in sublining macrophages explained 76% of the variation in the change in DAS28 (p<0.02). The sensitivity to change of the biomarker was high in patients treated actively (SRM >0.8), whereas the ability to detect changes in placebo treated patients was weak (SRM <0.3).

Conclusion: The results suggest that changes in synovial sublining macrophages can be used to predict possible efficacy of antirheumatic treatment.

Abbreviations: DAS28, 28 joint count Disease Activity Score; DMARDs, disease modifying antirheumatic drugs; IL, interleukin; LEF, leflunomide; MTX, methotrexate; RA, rheumatoid arthritis; SRM, standardised response mean; ST, synovial tissue; TNF, tumour necrosis factor

Keywords: arthroscopy; biomarkers; macrophages; rheumatoid arthritis; synovial tissue

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• BRESNIHAN, B., PONTIFEX, E., THURLINGS, R. M., VINKENOOG, M., EL-GABALAWY, H., FEARON, U., FITZGERALD, O., GERLAG, D. M., ROONEY, T., van de SANDE, M. G., VEALE, D., VOS, K., TAK, P.-P. (2009). Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers. The Journal of Rheumatology 36: 1800-1802 [Abstract] [Full Text]  
• van Kuijk, A W R, Gerlag, D M, Vos, K, Wolbink, G, de Groot, M, de Rie, M A, Zwinderman, A H, Dijkmans, B A C, Tak, P P (2009). A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue. Ann Rheum Dis 68: 1303-1309 [Abstract] [Full Text]  
• Canete, J D, Celis, R, Moll, C, Izquierdo, E, Marsal, S, Sanmarti, R, Palacin, A, Lora, D, de la Cruz, J, Pablos, J L (2009). Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor {alpha} therapy in rheumatoid arthritis. Ann Rheum Dis 68: 751-756 [Abstract] [Full Text]  
• Thurlings, R M, Vos, K, Wijbrandts, C A, Zwinderman, A H, Gerlag, D M, Tak, P P (2008). Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann Rheum Dis 67: 917-925 [Abstract] [Full Text]  
• Churchman, S. M., Ponchel, F. (2008). Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford) 47: 753-759 [Abstract] [Full Text]  
• Pessler, F, Ogdie, A, Diaz-Torne, C, Dai, L, Yu, X, Einhorn, E, Gay, S, Schumacher, H R (2008). Subintimal Ki-67 as a synovial tissue biomarker for inflammatory arthropathies. Ann Rheum Dis 67: 162-167 [Abstract] [Full Text]  
• Rooney, T., Bresnihan, B., Andersson, U., Gogarty, M., Kraan, M., Schumacher, H R., Ulfgren, A.-K., Veale, D. J, Youssef, P. P, Tak, P. P (2007). Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis. Ann Rheum Dis 66: 1656-1660 [Abstract] [Full Text]  
• Vergunst, C. E., Gerlag, D. M., Dinant, H., Schulz, L., Vinkenoog, M., Smeets, T. J. M., Sanders, M. E., Reedquist, K. A., Tak, P. P. (2007). Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation. Rheumatology (Oxford) 46: 1773-1778 [Abstract] [Full Text]  
• Gerlag, D. M, Boyle, D. L, Rosengren, S., Nash, T., Tak, P. P, Firestein, G. S (2007). Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment. Ann Rheum Dis 66: 545-547 [Abstract] [Full Text]  
• Jahangier, Z N, Jacobs, J W G, Kraan, M C, Wenting, M J G, Smeets, T J, Bijlsma, J W J, Lafeber, F P J G, Tak, P P (2006). Pretreatment macrophage infiltration of the synovium predicts the clinical effect of both radiation synovectomy and intra-articular glucocorticoids. Ann Rheum Dis 65: 1286-1292 [Abstract] [Full Text]  
• Baeten, D, Houbiers, J, Kruithof, E, Vandooren, B, Van den Bosch, F, Boots, A M, Veys, E M, Miltenburg, A M M, De Keyser, F (2006). Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis. Ann Rheum Dis 65: 990-997 [Abstract] [Full Text]  
• Smith, M D, Baeten, D, Ulfgren, A-K, McInnes, I B, Fitzgerald, O, Bresnihan, B, Tak, P P, Veale, D, on behalf of the OMERACT synovial special interest, (2006). Standardisation of synovial tissue infiltrate analysis: how far have we come? how much further do we need to go?. Ann Rheum Dis 65: 93-100 [Abstract] [Full Text]  
• Franz, J K, Burmester, G-R (2005). The needle and the damage done. Ann Rheum Dis 64: 798-800 [Full Text]